Recent News

By Category: Biosafety

Pentagon To Develop Q Fever Vaccine; U.S. Military To Focus On Biological Weapons Defense

(MedicalDaily) Next month, the Pentagon will host a seminar for researchers interested in developing a vaccine for the virus that causes Q fever, an animal-borne illness “weaponized” first by the U.S. and then the Soviet Union decades ago.

November 18, 2013
| Filed under Europe, North America, Biosafety, Bioterrorism, and Research
Share

U.S. Sees Progress in Central Asian Biosecurity

(NuclearThreatInitiative) Developing countries in Central Asia are making notable strides in their attempts to increase their governmental capacity to guard against biological-weapon threats, according to the U.S. State Department. Deputy Assistant Secretary of State for Nonproliferation Simon Limage on Friday noted how countries in the region — which stretches from the Caspian Sea in the Read More »

November 12, 2013
| Filed under Asia/Pacific, North America, Biosafety, and International
Share

D.C.’s Public Health Laboratory Gets Federal Approval to Open Region’s First Biosafety Level 3 Lab

(LabManager) The District has received approval from the Centers for Disease Control and Prevention to begin operations at the first Biosafety Level 3 laboratory in the national capital region, Department of Forensic Sciences Director Max Houck announced. That means the city’s Public Health Laboratory can now conduct biological analysis that will identify dozens of materials Read More »

November 7, 2013
| Filed under North America, Biosafety, and Research
Share

UT Southwestern To Collaborate On Soligenix’s RiVax Ricin Vaccine For Biodefense

(BioNewsTexas) Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing biodefense medical countermeasures (MCMs), announced that they have submitted a full contract proposal to the National Institute of Allergy and Infectious Diseases (NIAID), Division of Microbiology and Infectious Diseases, for the advanced development of RiVax™, a vaccine MCM candidate against ricin. A multi-year, multi-million Read More »

November 5, 2013
| Filed under North America, Biosafety, and Research
Share

FAZD Center’s Enhanced Passive Surveillance System

(GlobalBiodefense) The National Center for Foreign Animal and Zoonotic Disease Defense (FAZD) last month received $2 million in federal funds from the Department of Homeland Security’s Science and Technology Directorate to develop a disease-surveillance technology designed to protect U.S. animal agriculture from potentially catastrophic outbreaks of infectious pathogens. The project has the potential for a Read More »